speb/financial-data huggingface dataset:
CMCT income_statement (annual, 2022-12-31) — Basic EPS: -27815.53
CMCT cash_flow (annual, 2022-12-31) — Beginning Cash Position: 33651000.00
CMCT cash_flow (annual, 2022-12-31) — Capital Expenditure: -8816000.00
CMCT cash_flow (annual, 2022-12-31) — Capital Expenditure Reported: -8816000.00
CMCT balance_sheet (annual, 2022-12-31) — Capital Stock: 353482000.00
CMCT balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 46190000.00
CMCT balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 46190000.00
CMCT cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -31985000.00
CMCT cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 13693000.00
CMCT cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -22274000.00
CMCT cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 32410000.00
CMCT cash_flow (annual, 2022-12-31) — Change In Account Payable: 801000.00
CMCT cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -40000.00
CMCT cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 995000.00
CMCT cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -2056000.00
CMCT cash_flow (annual, 2022-12-31) — Change In Payable: 4415000.00
CMCT cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 4415000.00
CMCT cash_flow (annual, 2022-12-31) — Change In Receivables: -480000.00
CMCT cash_flow (annual, 2022-12-31) — Change In Working Capital: 2834000.00
CMCT cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -480000.00
CMCT cash_flow (annual, 2022-12-31) — Changes In Cash: 23829000.00
CMCT balance_sheet (annual, 2022-12-31) — Common Stock: 23000.00
CMCT cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -7658000.00
CMCT balance_sheet (annual, 2022-12-31) — Common Stock Equity: 23898000.00
CMCT cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
CMCT cash_flow (annual, 2022-12-31) — Common Stock Payments: -4715000.00
CMCT income_statement (annual, 2022-12-31) — Cost Of Revenue: 54380000.00
CMCT balance_sheet (annual, 2022-12-31) — Current Assets: 161350000.00
CMCT balance_sheet (annual, 2022-12-31) — Current Liabilities: 110375000.00
CMCT balance_sheet (annual, 2022-12-31) — Current Notes Payable: 0.00
CMCT cash_flow (annual, 2022-12-31) — Deferred Income Tax: -3000.00
CMCT cash_flow (annual, 2022-12-31) — Deferred Tax: -3000.00
CMCT cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 20497000.00
CMCT income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 20348000.00
CMCT cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 20497000.00
CMCT income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 20348000.00
CMCT income_statement (annual, 2022-12-31) — Diluted Average Shares: 927.00
CMCT income_statement (annual, 2022-12-31) — Diluted EPS: -27815.53
CMCT income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -25794000.00
CMCT balance_sheet (annual, 2022-12-31) — Dueto Related Parties Current: 3155000.00
CMCT income_statement (annual, 2022-12-31) — EBIT: 16680000.00
CMCT income_statement (annual, 2022-12-31) — EBITDA: 37177000.00
CMCT income_statement (annual, 2022-12-31) — Earnings From Equity Interest: 164000.00
CMCT cash_flow (annual, 2022-12-31) — Earnings Losses From Equity Investments: 0.00
CMCT cash_flow (annual, 2022-12-31) — End Cash Position: 57480000.00
CMCT cash_flow (annual, 2022-12-31) — Financing Cash Flow: 13693000.00
CMCT cash_flow (annual, 2022-12-31) — Free Cash Flow: 23594000.00
CMCT income_statement (annual, 2022-12-31) — General And Administrative Expense: 10439000.00
CMCT balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 4461000.00
CMCT income_statement (annual, 2022-12-31) — Gross Profit: 47526000.00
CMCT cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 1105000.00
CMCT income_statement (annual, 2022-12-31) — Interest Expense: 9604000.00
CMCT income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 9604000.00
CMCT cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 8388000.00
CMCT balance_sheet (annual, 2022-12-31) — Invested Capital: 208165000.00
CMCT cash_flow (annual, 2022-12-31) — Investing Cash Flow: -22274000.00
CMCT balance_sheet (annual, 2022-12-31) — Investment Properties: 502006000.00
CMCT balance_sheet (annual, 2022-12-31) — Investments And Advances: 12381000.00
CMCT cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 148007000.00
CMCT cash_flow (annual, 2022-12-31) — Issuance Of Debt: 166230000.00
CMCT balance_sheet (annual, 2022-12-31) — Loans Receivable: 62547000.00
CMCT balance_sheet (annual, 2022-12-31) — Long Term Debt: 184267000.00
CMCT balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 184267000.00
CMCT cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 166230000.00
CMCT cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -183392000.00
CMCT balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 12381000.00
CMCT balance_sheet (annual, 2022-12-31) — Minority Interest: 373000.00
CMCT income_statement (annual, 2022-12-31) — Minority Interests: -27000.00
CMCT cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -12381000.00
CMCT cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -4715000.00
CMCT balance_sheet (annual, 2022-12-31) — Net Debt: 138077000.00
CMCT income_statement (annual, 2022-12-31) — Net Income: 5918000.00
CMCT income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -25785000.00
CMCT income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 5945000.00
CMCT income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 5918000.00
CMCT income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 5918000.00
CMCT cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 5945000.00
CMCT income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 5945000.00
CMCT income_statement (annual, 2022-12-31) — Net Interest Income: -9604000.00
CMCT cash_flow (annual, 2022-12-31) — Net Investment Properties Purchase And Sale: -10787000.00
CMCT cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -17162000.00
CMCT cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -17162000.00
CMCT income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -9604000.00
CMCT cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -4508000.00
CMCT cash_flow (annual, 2022-12-31) — Net Other Investing Changes: 9710000.00
CMCT cash_flow (annual, 2022-12-31) — Net Preferred Stock Issuance: 72063000.00
CMCT cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: -16470000.00
CMCT balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 372896000.00
CMCT income_statement (annual, 2022-12-31) — Normalized EBITDA: 37400000.00
CMCT income_statement (annual, 2022-12-31) — Normalized Income: 6105356.56
CMCT cash_flow (annual, 2022-12-31) — Operating Cash Flow: 32410000.00
CMCT income_statement (annual, 2022-12-31) — Operating Income: 16739000.00
CMCT income_statement (annual, 2022-12-31) — Operating Revenue: 101906000.00
CMCT balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 927.00
CMCT income_statement (annual, 2022-12-31) — Other Gand A: 10439000.00
CMCT income_statement (annual, 2022-12-31) — Other Income Expense: -59000.00
CMCT balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 4461000.00
CMCT cash_flow (annual, 2022-12-31) — Other Non Cash Items: 2628000.00
CMCT balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 10050000.00
CMCT balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 17876000.00
CMCT balance_sheet (annual, 2022-12-31) — Other Receivables: 37543000.00
CMCT income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 13126000.00
CMCT balance_sheet (annual, 2022-12-31) — Payables: 110375000.00
CMCT balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 110375000.00
CMCT balance_sheet (annual, 2022-12-31) — Preferred Shares Number: 8080740.00
CMCT balance_sheet (annual, 2022-12-31) — Preferred Stock: 353459000.00
CMCT cash_flow (annual, 2022-12-31) — Preferred Stock Dividend Paid: -24327000.00
CMCT income_statement (annual, 2022-12-31) — Preferred Stock Dividends: 18577000.00
CMCT balance_sheet (annual, 2022-12-31) — Preferred Stock Equity: 353459000.00
CMCT cash_flow (annual, 2022-12-31) — Preferred Stock Issuance: 148007000.00
CMCT cash_flow (annual, 2022-12-31) — Preferred Stock Payments: -75944000.00
CMCT income_statement (annual, 2022-12-31) — Pretax Income: 7076000.00
CMCT cash_flow (annual, 2022-12-31) — Purchase Of Business: -22652000.00
CMCT cash_flow (annual, 2022-12-31) — Purchase Of Investment Properties: -10787000.00
CMCT balance_sheet (annual, 2022-12-31) — Receivables: 103870000.00
CMCT income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 54231000.00
CMCT income_statement (annual, 2022-12-31) — Reconciled Depreciation: 20497000.00
CMCT income_statement (annual, 2022-12-31) — Rent Expense Supplemental: 50526000.00
CMCT cash_flow (annual, 2022-12-31) — Repayment Of Debt: -183392000.00
CMCT cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -80659000.00
CMCT balance_sheet (annual, 2022-12-31) — Restricted Cash: 11290000.00
CMCT income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 223000.00
CMCT balance_sheet (annual, 2022-12-31) — Retained Earnings: -837846000.00
CMCT cash_flow (annual, 2022-12-31) — Sale Of Business: 10271000.00
CMCT cash_flow (annual, 2022-12-31) — Sale Of Investment Properties: 0.00
CMCT income_statement (annual, 2022-12-31) — Selling General And Administration: 10439000.00
CMCT balance_sheet (annual, 2022-12-31) — Share Issued: 927.00
CMCT cash_flow (annual, 2022-12-31) — Short Term Debt Issuance: 166230000.00
CMCT cash_flow (annual, 2022-12-31) — Short Term Debt Payments: -182700000.00
CMCT income_statement (annual, 2022-12-31) — Special Income Charges: -223000.00
CMCT cash_flow (annual, 2022-12-31) — Stock Based Compensation: 202000.00
CMCT balance_sheet (annual, 2022-12-31) — Stockholders Equity: 377357000.00
CMCT balance_sheet (annual, 2022-12-31) — Tangible Book Value: 19437000.00
CMCT income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -35643.44
CMCT income_statement (annual, 2022-12-31) — Tax Provision: 1131000.00
CMCT income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.16
CMCT balance_sheet (annual, 2022-12-31) — Total Assets: 690248000.00
CMCT balance_sheet (annual, 2022-12-31) — Total Capitalization: 561624000.00
CMCT balance_sheet (annual, 2022-12-31) — Total Debt: 184267000.00
CMCT balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 377730000.00
CMCT income_statement (annual, 2022-12-31) — Total Expenses: 85167000.00
CMCT balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 312518000.00
CMCT balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 528898000.00
CMCT balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 202143000.00
CMCT income_statement (annual, 2022-12-31) — Total Unusual Items: -223000.00
CMCT income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -223000.00
CMCT balance_sheet (annual, 2022-12-31) — Working Capital: 50975000.00
CMCT income_statement (annual, 2023-12-31) — +Operating Expense: 63230000.00
CMCT income_statement (annual, 2023-12-31) — +Total Revenue: 119258000.00
CMCT balance_sheet (annual, 2023-12-31) — Accounts Payable: 26426000.00
CMCT balance_sheet (annual, 2023-12-31) — Accounts Receivable: 5347000.00
CMCT balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 852476000.00
CMCT cash_flow (annual, 2023-12-31) — Amortization Of Securities: -59000.00
CMCT cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 299000.00
CMCT income_statement (annual, 2023-12-31) — Average Dilution Earnings: 0.00
CMCT income_statement (annual, 2023-12-31) — Basic Average Shares: 929.00
CMCT income_statement (annual, 2023-12-31) — Basic EPS: -81514.53
CMCT cash_flow (annual, 2023-12-31) — Beginning Cash Position: 57480000.00
CMCT cash_flow (annual, 2023-12-31) — Capital Expenditure: -13326000.00
CMCT cash_flow (annual, 2023-12-31) — Capital Expenditure Reported: -13326000.00
CMCT balance_sheet (annual, 2023-12-31) — Capital Stock: 443852000.00
CMCT balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 19290000.00
CMCT balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 19290000.00
CMCT cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -37232000.00
CMCT cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 63446000.00
CMCT cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -88695000.00
CMCT cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 11997000.00
CMCT cash_flow (annual, 2023-12-31) — Change In Account Payable: 10407000.00
CMCT cash_flow (annual, 2023-12-31) — Change In Other Current Assets: 2062000.00
CMCT cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -4875000.00
CMCT cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -1049000.00
CMCT cash_flow (annual, 2023-12-31) — Change In Payable: 10715000.00
CMCT cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 10715000.00
CMCT cash_flow (annual, 2023-12-31) — Change In Receivables: -1991000.00
CMCT cash_flow (annual, 2023-12-31) — Change In Working Capital: 4862000.00
CMCT cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -1991000.00
CMCT cash_flow (annual, 2023-12-31) — Changes In Cash: -13252000.00
CMCT balance_sheet (annual, 2023-12-31) — Common Stock: 23000.00
CMCT cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -7732000.00
CMCT balance_sheet (annual, 2023-12-31) — Common Stock Equity: -69426000.00
CMCT cash_flow (annual, 2023-12-31) — Common Stock Payments: 0.00
CMCT income_statement (annual, 2023-12-31) — Cost Of Revenue: 67414000.00
CMCT balance_sheet (annual, 2023-12-31) — Current Assets: 134802000.00
CMCT balance_sheet (annual, 2023-12-31) — Current Debt: 41394000.00
CMCT balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 41394000.00
CMCT balance_sheet (annual, 2023-12-31) — Current Liabilities: 71283000.00
CMCT balance_sheet (annual, 2023-12-31) — Current Notes Payable: 41394000.00
CMCT cash_flow (annual, 2023-12-31) — Deferred Income Tax: 42000.00
CMCT cash_flow (annual, 2023-12-31) — Deferred Tax: 42000.00
CMCT cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 52669000.00
CMCT income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 52484000.00
CMCT cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 52669000.00
CMCT income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 52484000.00
CMCT income_statement (annual, 2023-12-31) — Diluted Average Shares: 929.00
CMCT income_statement (annual, 2023-12-31) — Diluted EPS: -81514.53
CMCT income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -75727000.00
CMCT balance_sheet (annual, 2023-12-31) — Dueto Related Parties Current: 3463000.00
CMCT income_statement (annual, 2023-12-31) — EBIT: -15130000.00
CMCT income_statement (annual, 2023-12-31) — EBITDA: 37539000.00
CMCT income_statement (annual, 2023-12-31) — Earnings From Equity Interest: -427000.00
CMCT cash_flow (annual, 2023-12-31) — Earnings Losses From Equity Investments: 1755000.00
CMCT cash_flow (annual, 2023-12-31) — End Cash Position: 44228000.00
CMCT cash_flow (annual, 2023-12-31) — Financing Cash Flow: 63446000.00
CMCT cash_flow (annual, 2023-12-31) — Free Cash Flow: -1329000.00
CMCT cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: -1643000.00
CMCT income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 1104000.00
CMCT income_statement (annual, 2023-12-31) — General And Administrative Expense: 10746000.00
CMCT balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 3948000.00
CMCT income_statement (annual, 2023-12-31) — Gross Profit: 51844000.00
CMCT cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 1560000.00
CMCT income_statement (annual, 2023-12-31) — Interest Expense: 35098000.00
CMCT income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 35098000.00
CMCT cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 31079000.00
CMCT balance_sheet (annual, 2023-12-31) — Invested Capital: 402135000.00
CMCT cash_flow (annual, 2023-12-31) — Investing Cash Flow: -88695000.00
CMCT balance_sheet (annual, 2023-12-31) — Investment Properties: 704762000.00
CMCT balance_sheet (annual, 2023-12-31) — Investments And Advances: 33505000.00
CMCT cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 103228000.00
CMCT cash_flow (annual, 2023-12-31) — Issuance Of Debt: 389023000.00
CMCT balance_sheet (annual, 2023-12-31) — Loans Receivable: 57005000.00
CMCT balance_sheet (annual, 2023-12-31) — Long Term Debt: 430167000.00
CMCT balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 430167000.00
CMCT cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 389023000.00
CMCT cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -281319000.00
CMCT balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 33505000.00
CMCT balance_sheet (annual, 2023-12-31) — Minority Interest: 2366000.00
CMCT income_statement (annual, 2023-12-31) — Minority Interests: 2971000.00
CMCT cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -14279000.00
CMCT cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 0.00
CMCT balance_sheet (annual, 2023-12-31) — Net Debt: 452271000.00
CMCT income_statement (annual, 2023-12-31) — Net Income: -48485000.00
CMCT income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -75727000.00
CMCT income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -51456000.00
CMCT income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -48485000.00
CMCT income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -48485000.00
CMCT cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -51456000.00
CMCT income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -51456000.00
CMCT income_statement (annual, 2023-12-31) — Net Interest Income: -35098000.00
CMCT cash_flow (annual, 2023-12-31) — Net Investment Properties Purchase And Sale: -63427000.00
CMCT cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 107704000.00
CMCT cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 107704000.00
CMCT income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -35098000.00
CMCT cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -4108000.00
CMCT cash_flow (annual, 2023-12-31) — Net Other Investing Changes: 2337000.00
CMCT cash_flow (annual, 2023-12-31) — Net Preferred Stock Issuance: -2918000.00
CMCT cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: 56535000.00
CMCT balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 370455000.00
CMCT income_statement (annual, 2023-12-31) — Normalized EBITDA: 40856000.00
CMCT income_statement (annual, 2023-12-31) — Normalized Income: -45864570.00
CMCT cash_flow (annual, 2023-12-31) — Operating Cash Flow: 11997000.00
CMCT cash_flow (annual, 2023-12-31) — Operating Gains Losses: 112000.00
CMCT income_statement (annual, 2023-12-31) — Operating Income: -11386000.00
CMCT income_statement (annual, 2023-12-31) — Operating Revenue: 119258000.00
CMCT balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 929.00
CMCT income_statement (annual, 2023-12-31) — Other Gand A: 10746000.00
CMCT income_statement (annual, 2023-12-31) — Other Income Expense: -3744000.00
CMCT balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 3948000.00
CMCT cash_flow (annual, 2023-12-31) — Other Non Cash Items: 5345000.00
CMCT balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 14183000.00
CMCT balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 12981000.00
CMCT balance_sheet (annual, 2023-12-31) — Other Receivables: 28222000.00
CMCT income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 1511000.00
CMCT balance_sheet (annual, 2023-12-31) — Payables: 29889000.00
CMCT balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 29889000.00
CMCT balance_sheet (annual, 2023-12-31) — Preferred Stock: 443829000.00
CMCT cash_flow (annual, 2023-12-31) — Preferred Stock Dividend Paid: -29500000.00
CMCT income_statement (annual, 2023-12-31) — Preferred Stock Dividends: 25731000.00
CMCT balance_sheet (annual, 2023-12-31) — Preferred Stock Equity: 443829000.00
CMCT cash_flow (annual, 2023-12-31) — Preferred Stock Issuance: 103228000.00
CMCT cash_flow (annual, 2023-12-31) — Preferred Stock Payments: -106146000.00
CMCT income_statement (annual, 2023-12-31) — Pretax Income: -50228000.00
CMCT cash_flow (annual, 2023-12-31) — Purchase Of Business: -14279000.00
CMCT cash_flow (annual, 2023-12-31) — Purchase Of Investment Properties: -96731000.00
CMCT balance_sheet (annual, 2023-12-31) — Receivables: 90574000.00
CMCT income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 67229000.00
CMCT income_statement (annual, 2023-12-31) — Reconciled Depreciation: 52669000.00
CMCT income_statement (annual, 2023-12-31) — Rent Expense Supplemental: 62493000.00
CMCT cash_flow (annual, 2023-12-31) — Repayment Of Debt: -281319000.00
CMCT cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -106146000.00
CMCT balance_sheet (annual, 2023-12-31) — Restricted Cash: 24938000.00
CMCT income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 4421000.00
CMCT balance_sheet (annual, 2023-12-31) — Retained Earnings: -921925000.00
CMCT cash_flow (annual, 2023-12-31) — Sale Of Business: 0.00
CMCT cash_flow (annual, 2023-12-31) — Sale Of Investment Properties: 33304000.00
CMCT income_statement (annual, 2023-12-31) — Selling General And Administration: 10746000.00
CMCT balance_sheet (annual, 2023-12-31) — Share Issued: 929.00
CMCT cash_flow (annual, 2023-12-31) — Short Term Debt Issuance: 334882000.00
CMCT cash_flow (annual, 2023-12-31) — Short Term Debt Payments: -278347000.00
CMCT income_statement (annual, 2023-12-31) — Special Income Charges: -4421000.00
CMCT cash_flow (annual, 2023-12-31) — Stock Based Compensation: 183000.00
CMCT balance_sheet (annual, 2023-12-31) — Stockholders Equity: 374403000.00
CMCT balance_sheet (annual, 2023-12-31) — Tangible Book Value: -73374000.00
CMCT income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -696570.00
CMCT income_statement (annual, 2023-12-31) — Tax Provision: 1228000.00
CMCT income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.21
CMCT balance_sheet (annual, 2023-12-31) — Total Assets: 891200000.00
CMCT balance_sheet (annual, 2023-12-31) — Total Capitalization: 804570000.00
CMCT balance_sheet (annual, 2023-12-31) — Total Debt: 471561000.00
CMCT balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 376769000.00
CMCT income_statement (annual, 2023-12-31) — Total Expenses: 130644000.00
CMCT balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 514431000.00
CMCT balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 756398000.00
CMCT balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 443148000.00
CMCT income_statement (annual, 2023-12-31) — Total Unusual Items: -3317000.00
CMCT income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -3317000.00
CMCT balance_sheet (annual, 2023-12-31) — Working Capital: 63519000.00
CMCT income_statement (quarterly, 2024-09-30) — Average Dilution Earnings: 0.00
CMCT cash_flow (quarterly, 2024-09-30) — Dividends Received Cfi: 0.00
CMCT income_statement (quarterly, 2024-09-30) — Impairment Of Capital Assets: 0.00
CMCT cash_flow (quarterly, 2024-09-30) — Issuance Of Capital Stock: 12577000.00
CMCT cash_flow (quarterly, 2024-09-30) — Preferred Stock Issuance: 12577000.00
CMCT cash_flow (quarterly, 2024-09-30) — Purchase Of Investment Properties: 0.00
CMCT income_statement (annual, 2024-12-31) — +Operating Expense: 36174000.00
CMCT income_statement (annual, 2024-12-31) — +Total Revenue: 124512000.00
CMCT balance_sheet (annual, 2024-12-31) — Accounts Payable: 32204000.00
CMCT balance_sheet (annual, 2024-12-31) — Accounts Receivable: 4345000.00
CMCT balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 994973000.00
CMCT cash_flow (annual, 2024-12-31) — Amortization Of Securities: 24000.00
CMCT cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 1754000.00
CMCT balance_sheet (annual, 2024-12-31) — Assets Held For Sale Current: 0.00
CMCT balance_sheet (quarterly, 2024-12-31) — Assets Held For Sale Current: 0.00
CMCT income_statement (annual, 2024-12-31) — Average Dilution Earnings: 0.00
CMCT income_statement (quarterly, 2024-12-31) — Average Dilution Earnings: 0.00
CMCT income_statement (annual, 2024-12-31) — Basic Average Shares: 1704.00
CMCT income_statement (annual, 2024-12-31) — Basic EPS: -43025.00
CMCT cash_flow (annual, 2024-12-31) — Beginning Cash Position: 44228000.00
CMCT cash_flow (annual, 2024-12-31) — Capital Expenditure: -23262000.00
CMCT cash_flow (annual, 2024-12-31) — Capital Expenditure Reported: -23262000.00
CMCT balance_sheet (annual, 2024-12-31) — Capital Stock: 332821000.00
CMCT balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 20262000.00
CMCT balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 20262000.00
CMCT cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -31385000.00
CMCT cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 13902000.00
CMCT cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -22288000.00
CMCT cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 17026000.00
CMCT cash_flow (annual, 2024-12-31) — Change In Account Payable: -2023000.00
CMCT cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 4670000.00
CMCT cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -2493000.00
CMCT cash_flow (annual, 2024-12-31) — Change In Other Working Capital: -1840000.00
CMCT cash_flow (annual, 2024-12-31) — Change In Payable: 8582000.00
CMCT cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 8582000.00
CMCT cash_flow (annual, 2024-12-31) — Change In Receivables: 91000.00
CMCT cash_flow (annual, 2024-12-31) — Change In Working Capital: 9010000.00
CMCT cash_flow (annual, 2024-12-31) — Changes In Account Receivables: 91000.00
CMCT cash_flow (annual, 2024-12-31) — Changes In Cash: 8640000.00
CMCT balance_sheet (annual, 2024-12-31) — Common Stock: 119000.00
CMCT cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -5811000.00
CMCT cash_flow (quarterly, 2024-12-31) — Common Stock Dividend Paid: 0.00
CMCT balance_sheet (annual, 2024-12-31) — Common Stock Equity: -7387000.00
CMCT income_statement (annual, 2024-12-31) — Cost Of Revenue: 72814000.00
CMCT balance_sheet (annual, 2024-12-31) — Current Assets: 126354000.00
CMCT balance_sheet (annual, 2024-12-31) — Current Debt: 27857000.00
CMCT balance_sheet (quarterly, 2024-12-31) — Current Debt: 27857000.00
CMCT balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 27857000.00
CMCT balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 27857000.00
CMCT balance_sheet (annual, 2024-12-31) — Current Liabilities: 74129000.00
CMCT balance_sheet (annual, 2024-12-31) — Current Notes Payable: 27857000.00
CMCT balance_sheet (quarterly, 2024-12-31) — Current Notes Payable: 27857000.00
CMCT cash_flow (annual, 2024-12-31) — Deferred Income Tax: -36000.00
CMCT cash_flow (annual, 2024-12-31) — Deferred Tax: -36000.00
CMCT cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 27732000.00
CMCT income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 27373000.00
CMCT cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 27732000.00
CMCT income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 27373000.00
CMCT income_statement (annual, 2024-12-31) — Diluted Average Shares: 1704.00
CMCT income_statement (annual, 2024-12-31) — Diluted EPS: -43025.00
CMCT income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -73343000.00
CMCT balance_sheet (annual, 2024-12-31) — Dueto Related Parties Current: 14068000.00
CMCT income_statement (annual, 2024-12-31) — EBIT: 11920000.00
CMCT income_statement (annual, 2024-12-31) — EBITDA: 39652000.00
CMCT income_statement (annual, 2024-12-31) — Earnings From Equity Interest: -806000.00
CMCT cash_flow (annual, 2024-12-31) — Earnings Losses From Equity Investments: 806000.00
CMCT cash_flow (annual, 2024-12-31) — End Cash Position: 52868000.00
CMCT cash_flow (annual, 2024-12-31) — Financing Cash Flow: 13902000.00
CMCT cash_flow (annual, 2024-12-31) — Free Cash Flow: -6236000.00
CMCT cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: -463000.00
CMCT income_statement (annual, 2024-12-31) — Gain On Sale Of Ppe: 0.00
CMCT income_statement (annual, 2024-12-31) — General And Administrative Expense: 8801000.00
CMCT balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 3568000.00
CMCT income_statement (annual, 2024-12-31) — Gross Profit: 51698000.00
CMCT income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 0.00
CMCT cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 845000.00
CMCT cash_flow (quarterly, 2024-12-31) — Income Tax Paid Supplemental Data: 479000.00
CMCT income_statement (annual, 2024-12-31) — Interest Expense: 36872000.00
CMCT income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 36872000.00
CMCT cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 34874000.00
CMCT balance_sheet (annual, 2024-12-31) — Invested Capital: 498345000.00
CMCT cash_flow (annual, 2024-12-31) — Investing Cash Flow: -22288000.00
CMCT balance_sheet (annual, 2024-12-31) — Investment Properties: 709194000.00
CMCT balance_sheet (annual, 2024-12-31) — Investments And Advances: 33677000.00
CMCT balance_sheet (annual, 2024-12-31) — Investmentsin Joint Venturesat Cost: 33677000.00
CMCT balance_sheet (quarterly, 2024-12-31) — Investmentsin Joint Venturesat Cost: 33677000.00
CMCT cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 40445000.00
CMCT cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: -5000.00
CMCT cash_flow (annual, 2024-12-31) — Issuance Of Debt: 209746000.00
CMCT balance_sheet (annual, 2024-12-31) — Line Of Credit: 0.00
CMCT balance_sheet (quarterly, 2024-12-31) — Line Of Credit: 0.00
CMCT balance_sheet (annual, 2024-12-31) — Loans Receivable: 56210000.00
CMCT balance_sheet (quarterly, 2024-12-31) — Loans Receivable: 56210000.00
CMCT balance_sheet (annual, 2024-12-31) — Long Term Debt: 477875000.00
CMCT balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 477875000.00
CMCT cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 209746000.00
CMCT cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -173413000.00
CMCT balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 33677000.00
CMCT balance_sheet (annual, 2024-12-31) — Minority Interest: 1748000.00
CMCT income_statement (annual, 2024-12-31) — Minority Interests: 575000.00
CMCT cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: -978000.00
CMCT balance_sheet (annual, 2024-12-31) — Net Debt: 485470000.00
CMCT income_statement (annual, 2024-12-31) — Net Income: -25175000.00
CMCT income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -73343000.00
CMCT income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -25750000.00
CMCT income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -25175000.00
CMCT income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -25175000.00
CMCT cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -25750000.00
CMCT income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -25750000.00
CMCT income_statement (annual, 2024-12-31) — Net Interest Income: -36872000.00
CMCT cash_flow (annual, 2024-12-31) — Net Investment Properties Purchase And Sale: 1096000.00
CMCT cash_flow (quarterly, 2024-12-31) — Net Investment Properties Purchase And Sale: 0.00
CMCT cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 36333000.00
CMCT cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 36333000.00
CMCT income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -36872000.00
CMCT cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -6118000.00
CMCT cash_flow (annual, 2024-12-31) — Net Other Investing Changes: 856000.00
CMCT cash_flow (annual, 2024-12-31) — Net Preferred Stock Issuance: 15072000.00
CMCT balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 321747000.00
CMCT balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 6965000.00
CMCT balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Assets: 6965000.00
CMCT income_statement (annual, 2024-12-31) — Normalized EBITDA: 42450000.00
CMCT income_statement (annual, 2024-12-31) — Normalized Income: -22964580.00
CMCT cash_flow (annual, 2024-12-31) — Operating Cash Flow: 17026000.00
CMCT cash_flow (annual, 2024-12-31) — Operating Gains Losses: 1759000.00
CMCT income_statement (annual, 2024-12-31) — Operating Income: 15524000.00
CMCT income_statement (annual, 2024-12-31) — Operating Revenue: 124512000.00
CMCT balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 4661.00
CMCT cash_flow (annual, 2024-12-31) — Other Cash Adjustment Inside Changein Cash: 0.00
CMCT income_statement (annual, 2024-12-31) — Other Gand A: 8801000.00
CMCT income_statement (annual, 2024-12-31) — Other Income Expense: -3604000.00
CMCT balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 3568000.00
CMCT cash_flow (annual, 2024-12-31) — Other Non Cash Items: 2313000.00
CMCT balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 9797000.00
CMCT balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 10488000.00
CMCT balance_sheet (annual, 2024-12-31) — Other Receivables: 12931000.00
CMCT income_statement (annual, 2024-12-31) — Other Special Charges: 1416000.00
CMCT income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: 17727000.00
CMCT balance_sheet (annual, 2024-12-31) — Payables: 46272000.00
CMCT balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 46272000.00
CMCT balance_sheet (annual, 2024-12-31) — Preferred Stock: 332702000.00
CMCT cash_flow (annual, 2024-12-31) — Preferred Stock Dividend Paid: -25574000.00
CMCT income_statement (annual, 2024-12-31) — Preferred Stock Dividends: 30441000.00
CMCT balance_sheet (annual, 2024-12-31) — Preferred Stock Equity: 332702000.00
CMCT cash_flow (annual, 2024-12-31) — Preferred Stock Issuance: 40445000.00
CMCT cash_flow (quarterly, 2024-12-31) — Preferred Stock Issuance: -5000.00
CMCT cash_flow (annual, 2024-12-31) — Preferred Stock Payments: -25373000.00
CMCT income_statement (annual, 2024-12-31) — Pretax Income: -24952000.00
CMCT cash_flow (annual, 2024-12-31) — Purchase Of Business: -2263000.00
CMCT cash_flow (annual, 2024-12-31) — Purchase Of Investment Properties: 0.00
CMCT cash_flow (quarterly, 2024-12-31) — Purchase Of Investment Properties: 0.00
CMCT balance_sheet (annual, 2024-12-31) — Receivables: 73486000.00
CMCT income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 72455000.00
CMCT income_statement (annual, 2024-12-31) — Reconciled Depreciation: 27732000.00
CMCT income_statement (annual, 2024-12-31) — Rent Expense Supplemental: 67962000.00
CMCT cash_flow (annual, 2024-12-31) — Repayment Of Debt: -173413000.00
CMCT cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -25373000.00
CMCT balance_sheet (annual, 2024-12-31) — Restricted Cash: 32606000.00
CMCT income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 1382000.00
CMCT balance_sheet (annual, 2024-12-31) — Retained Earnings: -1002479000.00
CMCT cash_flow (annual, 2024-12-31) — Sale Of Business: 1285000.00
CMCT cash_flow (annual, 2024-12-31) — Sale Of Investment Properties: 1096000.00
CMCT cash_flow (quarterly, 2024-12-31) — Sale Of Investment Properties: 0.00
CMCT income_statement (annual, 2024-12-31) — Selling General And Administration: 8801000.00
CMCT balance_sheet (annual, 2024-12-31) — Share Issued: 4661.00
CMCT income_statement (annual, 2024-12-31) — Special Income Charges: -2798000.00
CMCT cash_flow (annual, 2024-12-31) — Stock Based Compensation: 220000.00
CMCT balance_sheet (annual, 2024-12-31) — Stockholders Equity: 325315000.00
CMCT balance_sheet (annual, 2024-12-31) — Tangible Book Value: -10955000.00
CMCT income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -587580.00
CMCT income_statement (annual, 2024-12-31) — Tax Provision: 798000.00
CMCT income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
CMCT balance_sheet (annual, 2024-12-31) — Total Assets: 889555000.00
CMCT balance_sheet (annual, 2024-12-31) — Total Capitalization: 803190000.00
CMCT balance_sheet (annual, 2024-12-31) — Total Debt: 505732000.00
CMCT balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 327063000.00
CMCT income_statement (annual, 2024-12-31) — Total Expenses: 108988000.00
CMCT balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 562492000.00
CMCT balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 763201000.00
CMCT balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 488363000.00
CMCT income_statement (annual, 2024-12-31) — Total Unusual Items: -2798000.00
CMCT income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -2798000.00
CMCT balance_sheet (annual, 2024-12-31) — Working Capital: 52225000.00
CMCT income_statement (quarterly, 2025-03-31) — +Operating Expense: 8741000.00
CMCT income_statement (quarterly, 2025-03-31) — +Total Revenue: 32295000.00
CMCT balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 26656000.00
CMCT balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 3844000.00
CMCT balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 1002913000.00
CMCT cash_flow (quarterly, 2025-03-31) — Amortization Of Securities: 26000.00
CMCT cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 168000.00
CMCT income_statement (quarterly, 2025-03-31) — Average Dilution Earnings: 0.00
CMCT income_statement (quarterly, 2025-03-31) — Basic Average Shares: 7546.00
CMCT income_statement (quarterly, 2025-03-31) — Basic EPS: -1576.73
CMCT cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 52868000.00
CMCT cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -6316000.00
CMCT cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -6316000.00
CMCT balance_sheet (quarterly, 2025-03-31) — Capital Stock: 325303000.00
CMCT balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 19772000.00
CMCT balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 19772000.00
CMCT cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -5965000.00
CMCT cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 206000.00
CMCT cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -5157000.00
CMCT cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 1208000.00
CMCT cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -1636000.00
CMCT cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: -4184000.00
CMCT cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -1091000.00
CMCT cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -949000.00
CMCT cash_flow (quarterly, 2025-03-31) — Change In Payable: 2494000.00
CMCT cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 2494000.00
CMCT cash_flow (quarterly, 2025-03-31) — Change In Receivables: 372000.00
CMCT cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -3358000.00
CMCT cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 372000.00
CMCT cash_flow (quarterly, 2025-03-31) — Changes In Cash: -3743000.00
CMCT balance_sheet (quarterly, 2025-03-31) — Common Stock: 20000.00
CMCT cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: 0.00
CMCT balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: -11439000.00
CMCT income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 18770000.00
CMCT balance_sheet (quarterly, 2025-03-31) — Current Assets: 125349000.00
CMCT balance_sheet (quarterly, 2025-03-31) — Current Debt: 25263000.00
CMCT balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 25263000.00
CMCT balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 70117000.00
CMCT balance_sheet (quarterly, 2025-03-31) — Current Notes Payable: 25263000.00
CMCT cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -24000.00
CMCT cash_flow (quarterly, 2025-03-31) — Deferred Tax: -24000.00
CMCT cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 6634000.00
CMCT income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 6560000.00
CMCT cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 6634000.00
CMCT income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 6560000.00
CMCT income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 7546.00
CMCT income_statement (quarterly, 2025-03-31) — Diluted EPS: -1576.73
CMCT income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -11898000.00
CMCT balance_sheet (quarterly, 2025-03-31) — Dueto Related Parties Current: 18198000.00
CMCT income_statement (quarterly, 2025-03-31) — EBIT: 3607000.00
CMCT income_statement (quarterly, 2025-03-31) — EBITDA: 10241000.00
CMCT income_statement (quarterly, 2025-03-31) — Earnings From Equity Interest: -1151000.00
CMCT cash_flow (quarterly, 2025-03-31) — Earnings Losses From Equity Investments: 1151000.00
CMCT cash_flow (quarterly, 2025-03-31) — End Cash Position: 49125000.00
CMCT cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 206000.00
CMCT cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -5108000.00
CMCT cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of Business: 0.00
CMCT income_statement (quarterly, 2025-03-31) — Gain On Sale Of Business: 0.00
CMCT income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 2181000.00
CMCT balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 3488000.00
CMCT income_statement (quarterly, 2025-03-31) — Gross Profit: 13525000.00
CMCT cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 0.00
CMCT income_statement (quarterly, 2025-03-31) — Interest Expense: 9758000.00
CMCT income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 9758000.00
CMCT cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 7686000.00
CMCT balance_sheet (quarterly, 2025-03-31) — Invested Capital: 501219000.00
CMCT cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -5157000.00
CMCT balance_sheet (quarterly, 2025-03-31) — Investment Properties: 706537000.00
CMCT balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 33341000.00
CMCT cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 9013000.00
CMCT balance_sheet (quarterly, 2025-03-31) — Loans Receivable: 53039000.00
CMCT balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 487395000.00
CMCT balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 487395000.00
CMCT cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 9013000.00
CMCT cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -2606000.00
CMCT balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 33341000.00
CMCT balance_sheet (quarterly, 2025-03-31) — Minority Interest: 1590000.00
CMCT income_statement (quarterly, 2025-03-31) — Minority Interests: 158000.00
CMCT cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: -815000.00
CMCT balance_sheet (quarterly, 2025-03-31) — Net Debt: 492886000.00
CMCT income_statement (quarterly, 2025-03-31) — Net Income: -6114000.00
CMCT income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -11898000.00
CMCT income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -6272000.00
CMCT income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -6114000.00
CMCT income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -6114000.00
CMCT cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -6272000.00
CMCT income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -6272000.00
CMCT income_statement (quarterly, 2025-03-31) — Net Interest Income: -9758000.00
CMCT cash_flow (quarterly, 2025-03-31) — Net Investment Properties Purchase And Sale: 0.00
CMCT cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 6407000.00
CMCT cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 6407000.00
CMCT income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -9758000.00
CMCT cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -228000.00
CMCT cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: 1974000.00
CMCT cash_flow (quarterly, 2025-03-31) — Net Preferred Stock Issuance: -8000.00
CMCT balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 310356000.00
CMCT income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 10267000.00
CMCT income_statement (quarterly, 2025-03-31) — Normalized Income: -6093460.00
CMCT cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 1208000.00
CMCT cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 1151000.00
CMCT income_statement (quarterly, 2025-03-31) — Operating Income: 4784000.00
CMCT income_statement (quarterly, 2025-03-31) — Operating Revenue: 32295000.00
CMCT balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 7546.00
CMCT income_statement (quarterly, 2025-03-31) — Other Gand A: 2181000.00
CMCT income_statement (quarterly, 2025-03-31) — Other Income Expense: -1177000.00
CMCT balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 3488000.00
CMCT cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 2828000.00
CMCT balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 13628000.00
CMCT balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 9397000.00
CMCT balance_sheet (quarterly, 2025-03-31) — Other Receivables: 19341000.00
CMCT income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 300000.00
CMCT balance_sheet (quarterly, 2025-03-31) — Payables: 44854000.00
CMCT balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 44854000.00
CMCT balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 325283000.00
CMCT cash_flow (quarterly, 2025-03-31) — Preferred Stock Dividend Paid: -5965000.00
CMCT income_statement (quarterly, 2025-03-31) — Preferred Stock Dividends: 5484000.00
CMCT balance_sheet (quarterly, 2025-03-31) — Preferred Stock Equity: 325283000.00
CMCT cash_flow (quarterly, 2025-03-31) — Preferred Stock Payments: -8000.00
CMCT income_statement (quarterly, 2025-03-31) — Pretax Income: -6151000.00
CMCT cash_flow (quarterly, 2025-03-31) — Purchase Of Business: -815000.00
CMCT balance_sheet (quarterly, 2025-03-31) — Receivables: 76224000.00
CMCT income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 18696000.00
CMCT income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 6634000.00
CMCT income_statement (quarterly, 2025-03-31) — Rent Expense Supplemental: 17125000.00